About Secoya Technologies
Secoya Technologies is a partner specialised in pharmaceutical precision processes. Combining deep scientific knowledge with proprietary technologies and engineering capabilities, Secoya supports pharmaceutical and biotech companies from early research to process development and technical implementation at production scale.
Secoya Technologies provides expertise and equipment across four process technologies; crystallization, encapsulation, pervaporation and continuous chemical synthesis. Through close collaboration with clients, Secoya designs tailored process solutions and equipment.
By bridging scientific understanding with engineering execution, Secoya helps accelerate the development of robust and innovative pharmaceutical processes. Secoya holds a track record with key partners in the pharmaceutical industry.
OUR Core competencies
Process & Scientific Expertise
Deep knowledge in chemistry, material science and pharmaceutical processes.
This expertise includes:
- Organic & Flow chemistry
- Materials science
- Microfluidics
- Formulation development
- Manufacturing processes
Secoya supports clients at the R&D and process understanding stage
Engineering & Equipment Design
Secoya is able to translate and optimize processes into practical solutions.
This expertise includes:
- Custom process design
- Mechanical engineering
- Equipment development
- Adaptable ready-to-use systems
- On-site installation and qualification
Secoya develops equipment that solve process challenges
The team
CEO
Technology Lead – Emulsification & Droplet generation
Technology Lead – Pervaporation & Process Intensification
Technology Lead – Crystallization
Co-Founder
Co-Founder
Co-Founder
Business Development and Sales Lead
QA Responsible
R&D Scientist
Lab & Workshop Technician
Supply Chain Responsible
Board of directors
Our story
Introducing the SCT-LAB 2.0: The first equipment from the new SCT suite, SCT-LAB 2.0 revolutionizes crystallization screening with its high-speed capabilities. A new star is born in the world of crystallization technology!
Secoya launched the InstaDrop! By its conception, this bench equipment allows the easy control of flow and particle size. And as it includes our 𝗥𝗮𝘆𝗱𝗿𝗼𝗽® technology, the 𝗜𝗻𝘀𝘁𝗮𝗗𝗥𝗢𝗣 is perfectly suited for bead and capsule microencapsulation, preformulation screening and small batch production.
Secoya concluded its first contracts with major actors in the pharmaceutical industry, confirming the interests of our technologies. In parallel, Secoya performed internal projects to demonstrate further these benefits and in developing upscaling solutions for high quality industrial production
In October 2019, after raising funds from private investors, Secoya moved into its new headquarters gathering offices and laboratories within the scientific park of Louvain-la-Neuve, 20 minutes from Brussels. This is an ideal location, in the midst of a vibrant ecosystem of cutting-edge companies active in the fields of biotechnology and pharmaceuticals, and at the heart of a solid network of partners (precision mechanics, automation, engineering, imaging…) that is crucial to the development of its activities.
To successfully complete this project, they teamed up with a business manager and two “legal and investment” profiles who also became co-founders of the company. The interest expressed by certain major players in the pharmaceutical industry for this “multitechnological” company capable of apprehending in a holistic way the complex issues of drug manufacturing quickly confirmed the pertinence of this project. The company was not even been created when the first development contracts and equipment sales started being negotiated.
In 2018, the idea to give business value to these results within a single structure came to the mind of the future founders of Secoya. Their objective? To offer innovative and unique solutions to the pharmaceutical industry by gathering complementary expertise and technologies within one single entity.
Since 2012, the TIPs laboratory (Transfer, Interface and Processes) at the Université Libre de Bruxelles has been involved in various R&D projects that have led to the development of new technologies related to flow control in milli/microfluidic structures.
